Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,230,686
+$766,711 QoQ
Shares Held
34,775
+107.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#225
of 497 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 73%
Shared 27%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Dec 31, 2024CallValue
$591,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. ROIV ranks #30 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
134,214 | $40,402,439 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
223,995 | $21,835,032 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,306 | $13,908,683 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
347,106 | $10,850,533 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
5,112,098 | $8,521,240 | |
| 6 | ARGX |
Argenx SE
|
8,200 | $7,607,714 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
150,200 | $7,065,408 | |
| 8 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 |
All Filings in ROIV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,230,686 | 34,775 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $463,975 | 16,750 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $363,475 | 16,750 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,884,627 | 256,750 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,008,883 | 444,444 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,484,439 | 444,444 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $591,500 | 50,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $7,623,783 | 644,445 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,744,894 | 844,445 | Shares | Sole | 2024-11-07 | |
| 2024-09-30 | $4,039,000 | 350,000 | Call | Sole | 2024-11-07 | |
| 2024-06-30 | $528,500 | 50,000 | Call | Other | 2024-08-14 | |
| 2024-06-30 | $12,738,625 | 1,205,168 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $160,208 | 15,200 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $4,753,603 | 451,006 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||